Quercetin for Health & Longevity - Quick Reference Sheet

Quercetin for Health & Longevity

Created on 07/04/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Quercetin is an inexpensive plant compound found in common foods. Its most reliable benefit is a modest lowering of blood pressure, with fairly consistent reductions in uric acid and inflammation. Allergy, immune, and exercise uses rest on weaker evidence, and its longevity appeal remains largely unproven. Poorly absorbed, so form, dose, and taking it with food matter. (Full Review)

Protocol

Standard Dose
500–1,000 mg/day
500 mg once or twice daily, taken with a fat-containing meal
Form
Enhanced-absorption
Phytosome (lecithin-bound) or glucoside forms; plain quercetin is poorly absorbed
Senolytic Approach
1,000–1,250 mg/day, intermittent
Paired with dasatinib for a few days at a time; investigational
Time to effect
Blood Pressure
4–8 weeks
Biomarker reductions with consistent dosing
Uric Acid
4–8 weeks
Emerges over consistent dosing
Allergy & Immune
Sooner
May be felt earlier than biomarker effects

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Kidney disease (eGFR <60 mL/min/1.73m²), high doses
  • Narrow-therapeutic-index drugs (warfarin, cyclosporine, digoxin)
  • Hypothyroidism, large doses
  • Antiviral treatment
Key Interactions
  • Blood thinners & antiplatelet drugs (warfarin, clopidogrel)
  • CYP3A4-metabolized drugs (cyclosporine, statins, nifedipine, felodipine)
  • P-glycoprotein substrates (digoxin)
  • Certain antivirals (nirmatrelvir/ritonavir)
  • Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin)
  • Antihypertensive & antidiabetic drugs (amlodipine, lisinopril, losartan, metformin, insulin)
  • NSAIDs (ibuprofen, aspirin)
  • Iron supplements

Risk & Side Effects

  • High: Gastrointestinal discomfort
  • Medium: Headache & tingling sensations, kidney injury at high intravenous doses
  • Low: Thyroid hormone interference, reduced efficacy of some medications
  • Speculative: Pro-oxidant effects at excessive doses, estrogenic / hormonal activity

Monitoring

Marker Target Why
Blood pressure <120/80 mm Hg Primary demonstrated benefit
High-sensitivity CRP <1.0 mg/L Tracks the anti-inflammatory effect
Uric acid 3.5–5.5 mg/dL Reflects xanthine oxidase inhibition
Fasting glucose / HbA1c <90 mg/dL / <5.4% Monitors metabolic effect
LDL-cholesterol <100 mg/dL Captures the variable lipid effect
eGFR / creatinine eGFR >90 mL/min/1.73m² Safety check given high-dose kidney concern
ALT / AST ALT <25 U/L (men <30), AST <25 U/L Safety check for long-term use

Cadence: Baseline before starting; recheck at 8–12 weeks, then every 6–12 months for long-term use

Qualitative Assessment

  • Allergy and sinus symptoms
  • Energy and exercise recovery
  • Digestive comfort
  • General well-being